These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogs. Brooks DP; Valente M; Petrone G; Depalma PD; Sbacchi M; Clarke GD J Pharmacol Exp Ther; 1997 Mar; 280(3):1176-83. PubMed ID: 9067301 [TBL] [Abstract][Full Text] [Related]
9. Effect of niravoline (RU51599), a kappa-opioid receptor agonist, on tumour-origin brain oedema. Takahashi H; Hamada H; Teramoto A Acta Neurochir (Wien); 1999; 141(7):771-8. PubMed ID: 10481790 [TBL] [Abstract][Full Text] [Related]
10. The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke. Guéniau C; Oberlander C J Pharmacol Exp Ther; 1997 Jul; 282(1):1-6. PubMed ID: 9223533 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of niravoline, an arginine vasopressin inhibitor, on tumour-origin brain oedema. Takahashi H; Hamada H; Teramoto A Acta Neurochir Suppl; 2000; 76():323-7. PubMed ID: 11450035 [TBL] [Abstract][Full Text] [Related]
12. Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis. Komeichi H; Moreau R; Cailmail S; Gaudin C; Lebrec D J Hepatol; 1995 Mar; 22(3):319-25. PubMed ID: 7608483 [TBL] [Abstract][Full Text] [Related]
13. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves. Kapusta DR; Obih JC J Pharmacol Exp Ther; 1993 Oct; 267(1):197-204. PubMed ID: 8229746 [TBL] [Abstract][Full Text] [Related]
14. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus. Gottlieb HB; Varner KJ; Kenigs VA; Cabral AM; Kapusta DR J Pharmacol Exp Ther; 2005 Feb; 312(2):678-85. PubMed ID: 15381735 [TBL] [Abstract][Full Text] [Related]
16. Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats. Kapusta DR; Jones SY; DiBona GF J Pharmacol Exp Ther; 1989 Oct; 251(1):230-7. PubMed ID: 2552076 [TBL] [Abstract][Full Text] [Related]
17. Renal excretory responses produced by central administration of opioid agonists in ketamine and xylazine-anesthetized rats. Cabral AM; Varner KJ; Kapusta DR J Pharmacol Exp Ther; 1997 Aug; 282(2):609-16. PubMed ID: 9262322 [TBL] [Abstract][Full Text] [Related]
18. Kappa opioid-induced diuresis in female vs. male rats. Craft RM; Ulibarri CM; Raub DJ Pharmacol Biochem Behav; 2000 Jan; 65(1):53-9. PubMed ID: 10638636 [TBL] [Abstract][Full Text] [Related]
19. Contribution of alpha-2 adrenoceptors to kappa opioid agonist-induced water diuresis in the rat. Wang YX; Clarke GD; Sbacchi M; Petrone G; Brooks DP J Pharmacol Exp Ther; 1994 Jul; 270(1):244-9. PubMed ID: 8035321 [TBL] [Abstract][Full Text] [Related]
20. Central kappa opioids blunt the renal excretory responses to volume expansion by a renal nerve-dependent mechanism. Kapusta DR; Obih JC J Pharmacol Exp Ther; 1995 Apr; 273(1):199-205. PubMed ID: 7714767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]